These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

241 related items for PubMed ID: 15661032

  • 1. Genetic analysis of patients with defects in early B-cell development.
    Conley ME, Broides A, Hernandez-Trujillo V, Howard V, Kanegane H, Miyawaki T, Shurtleff SA.
    Immunol Rev; 2005 Feb; 203():216-34. PubMed ID: 15661032
    [Abstract] [Full Text] [Related]

  • 2. BTK mutations in patients with X-linked agammaglobulinemia: lack of correlation between presence of peripheral B lymphocytes and specific mutations.
    Tao L, Boyd M, Gonye G, Malone B, Schwaber J.
    Hum Mutat; 2000 Dec; 16(6):528-9. PubMed ID: 11102984
    [Abstract] [Full Text] [Related]

  • 3. The Bruton's tyrosine kinase gene is expressed throughout B cell differentiation, from early precursor B cell stages preceding immunoglobulin gene rearrangement up to mature B cell stages.
    de Weers M, Verschuren MC, Kraakman ME, Mensink RG, Schuurman RK, van Dongen JJ, Hendriks RW.
    Eur J Immunol; 1993 Dec; 23(12):3109-14. PubMed ID: 8258324
    [Abstract] [Full Text] [Related]

  • 4. Genotype/phenotype correlations in X-linked agammaglobulinemia.
    Broides A, Yang W, Conley ME.
    Clin Immunol; 2006 Dec; 118(2-3):195-200. PubMed ID: 16297664
    [Abstract] [Full Text] [Related]

  • 5. Composition of precursor B-cell compartment in bone marrow from patients with X-linked agammaglobulinemia compared with healthy children.
    Noordzij JG, de Bruin-Versteeg S, Comans-Bitter WM, Hartwig NG, Hendriks RW, de Groot R, van Dongen JJ.
    Pediatr Res; 2002 Feb; 51(2):159-68. PubMed ID: 11809909
    [Abstract] [Full Text] [Related]

  • 6. X-linked agammaglobulinemia in a 10-year-old boy with a novel non-invariant splice-site mutation in Btk gene.
    Maekawa K, Yamada M, Okura Y, Sato Y, Yamada Y, Kawamura N, Ariga T.
    Blood Cells Mol Dis; 2010 Apr 15; 44(4):300-4. PubMed ID: 20122858
    [Abstract] [Full Text] [Related]

  • 7. Genotype-phenotype correlation in Bruton's tyrosine kinase deficiency.
    Teimourian S, Nasseri S, Pouladi N, Yeganeh M, Aghamohammadi A.
    J Pediatr Hematol Oncol; 2008 Sep 15; 30(9):679-83. PubMed ID: 18776760
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Bruton's tyrosine kinase expression and activity in X-linked agammaglobulinaemia (XLA): the use of protein analysis as a diagnostic indicator of XLA.
    Gaspar HB, Lester T, Levinsky RJ, Kinnon C.
    Clin Exp Immunol; 1998 Feb 15; 111(2):334-8. PubMed ID: 9486400
    [Abstract] [Full Text] [Related]

  • 10. BTK: 22 novel and 25 recurrent mutations in European patients with X-linked agammaglobulinemia.
    Fiorini M, Franceschini R, Soresina A, Schumacher RF, Ugazio AG, Rossi P, Plebani A, Notarangelo LD.
    Hum Mutat; 2004 Mar 15; 23(3):286. PubMed ID: 14974089
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Bruton tyrosine kinase gene mutations in Turkish patients with presumed X-linked agammaglobulinemia.
    Wang Y, Kanegane H, Sanal O, Ersoy F, Tezcan I, Futatani T, Tsukada S, Miyawaki T.
    Hum Mutat; 2001 Oct 15; 18(4):356. PubMed ID: 11668622
    [Abstract] [Full Text] [Related]

  • 13. Identification of nine novel mutations in the Bruton's tyrosine kinase gene in X-linked agammaglobulinaemia patients.
    Orlandi P, Ritis K, Moschese V, Angelini F, Arvanitidis K, Speletas M, Sideras P, Plebani A, Rossi P.
    Hum Mutat; 2000 Jan 15; 15(1):117. PubMed ID: 10612838
    [Abstract] [Full Text] [Related]

  • 14. Bruton's tyrosine kinase: cell biology, sequence conservation, mutation spectrum, siRNA modifications, and expression profiling.
    Lindvall JM, Blomberg KE, Väliaho J, Vargas L, Heinonen JE, Berglöf A, Mohamed AJ, Nore BF, Vihinen M, Smith CI.
    Immunol Rev; 2005 Feb 15; 203():200-15. PubMed ID: 15661031
    [Abstract] [Full Text] [Related]

  • 15. Characterization of novel Bruton's tyrosine kinase gene mutations in Central European patients with agammaglobulinemia.
    Kristufek D, Aspalter RM, Eibl MM, Wolf HM.
    Mol Immunol; 2007 Mar 15; 44(7):1639-43. PubMed ID: 17045652
    [Abstract] [Full Text] [Related]

  • 16. Characterization of Bruton's tyrosine kinase mutations in Mexican patients with X-linked agammaglobulinemia.
    Lopez-Herrera G, Berron-Ruiz L, Mogica-Martinez D, Espinosa-Rosales F, Santos-Argumedo L.
    Mol Immunol; 2008 Feb 15; 45(4):1094-8. PubMed ID: 17765309
    [Abstract] [Full Text] [Related]

  • 17. xid affects events leading to B cell cycle entry.
    Brorson K, Brunswick M, Ezhevsky S, Wei DG, Berg R, Scott D, Stein KE.
    J Immunol; 1997 Jul 01; 159(1):135-43. PubMed ID: 9200448
    [Abstract] [Full Text] [Related]

  • 18. Clinical and mutational characteristics of X-linked agammaglobulinemia and its carrier identified by flow cytometric assessment combined with genetic analysis.
    Kanegane H, Futatani T, Wang Y, Nomura K, Shinozaki K, Matsukura H, Kubota T, Tsukada S, Miyawaki T.
    J Allergy Clin Immunol; 2001 Dec 01; 108(6):1012-20. PubMed ID: 11742281
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.